Annals of Pediatric Gastroenterology and Hepatology ISPGHAN

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  6 (2024)
Volume  5 (2023)
Volume  4 (2022)
Volume  3 (2021)
Volume  2 (2020)
Volume  1 (2019)
Related articles

VOLUME 5 , ISSUE 4 ( October-December, 2023 ) > List of Articles

REVIEW ARTICLE

Approach to a Child with Massive Hepatomegaly

Arghya Samanta, Moinak Sen Sarma

Keywords : Hepatic malignancy, Massive hepatomegaly, Storage disorder

Citation Information : Samanta A, Sarma MS. Approach to a Child with Massive Hepatomegaly. Ann Pediatr Gastroenterol Hepatol 2023; 5 (4):61-64.

DOI: 10.5005/jp-journals-11009-0147

License: CC BY-NC 4.0

Published Online: 22-01-2024

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Pediatricians/pediatric gastroenterologists should be aware of the causes of massive hepatomegaly in children and be able to differentiate benign diseases from those with a worse prognosis and evaluate accordingly. Clinical evaluation is of extreme importance, with keen attention to agewise etiologies and clinical pointers. Most disorders causing massive hepatology in children are potentially treatable with favorable outcomes if detected and treated early. This review discusses the approach for the evaluation of a child presenting with massive hepatomegaly.

HTML PDF Share
  1. Khanna R, Verma SK. Pediatric hepatocellular carcinoma. World J Gastroenterol 2018;24(35):3980–3999. DOI: 10.3748/wjg.v24.i35.3980
  2. Sen Sarma M, Tripathi PR. Natural history and management of liver dysfunction in lysosomal storage disorders. World J Hepatol 2022;14(10):1844–1861. DOI: 10.4254/wjh.v14.i10.1844
  3. Singh SK, Sarma MS. Hereditary fructose intolerance: a comprehensive review. World J Clin Pediatr 2022;11(4):321–329. DOI: 10.5409/wjcp.v11.i4.321
  4. Burton BK, Deegan PB, Enns GM, et al. Clinical features of lysosomal acid lipase deficiency. J Pediatr Gastroenterol Nutr 2015;61(6):619–625. DOI: 10.1097/MPG.0000000000000935
  5. Bay L, Canero Velasco C, Ciocca M, et al. Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D). Clinical and diagnostic aspects, and a new treatment. An update. Arch Argent Pediatr 2017;115(3):287–293. DOI: 10.5546/aap.2017.eng.287
  6. Kishnani PS, Austin SL, Arn P, et al. Glycogen storage disease type III diagnosis and management guidelines. Genet Med 2010;12(7):446–463. DOI: 10.1097/GIM.0b013e3181e655b6
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.